PLx Pharma PLXP
$ 0.09
-27.8%
Quarterly report 2022-Q3
added 11-10-2022
Country |
USA |
IPO year |
2014 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Mr. David Luci |
Employees in the company |
10 |
Shares |
23.7 M |
Market Cap[1] |
$ 2.56 M |
EBITDA (LTM) |
$ -53.2 M |
P/E (LTM) |
-0.09 |
P/S (LTM) |
0.54 |
EPS (LTM) |
-1.92 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.